Angitia Biopharmaceuticals raised $120M Series C venture round, led by Bain Capital Life Sciences.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Private Equity | — | |
| Private | — | |
| Venture Capital | — | |
| Private | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$206M
Top Valuation
-
Angitia Biopharmaceuticals raised $120M in a Series C round.
The round was announced on 12/11/24.
The round was led by Bain Capital Life Sciences.